Chairman Receives Prestigious Award

AI SummaryClose X

Hemogenyx's Chairman, Professor Sir Marc Feldmann, was awarded the Robert Koch Medal in Gold on 13 November 2026 for lifetime achievement in immunology, underscoring his role in establishing anti-TNF therapy and antibody therapeutics; the company says his scientific judgement will continue to guide its clinical programs, including lead program HG-CT-1, a Phase 1 CAR-T therapy for relapsed/refractory acute myeloid leukemia, which may be a positive signal for investor confidence and partnerships.

Disclaimer*

UK 100

Latest directors dealings